Loading company…
Riskpilot
← Back to search
Sign in
Get full access
RxPharma AB
AB
Active
Org 5594462201
Hagagatan 1 A
Temporary employment agency activities and other human resource provisions · NACE 7820
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 513K
-40% vs 2024
EBITDA margin
37.9%
-13% vs 2024
Equity ratio
79.8%
Financial strength
Net profit 2025
SEK 131K
-14% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 513K
-40%
EBITDA
SEK 195K
-13%
Net profit
SEK 131K
-14%
Total assets
SEK 199K
-27%
Equity
SEK 159K
-11%
Employees
0
—
Company information
Legal name
RxPharma AB
Org number
5594462201
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
29 augusti 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva bemanning, uthyrning av personal och verksamhetsutveckling inom hälsa, rådgivning och farmaci.
Contact
Address
Hagagatan 1 A
Email
hks.96@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Temporary employment agency activities and other human resource provisions
Companies in Habo
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
848
513
Staff expenses
−609
−298
EBITDA
223
195
Depreciation & amort.
—
—
EBIT
223
195
Net financials
−1
0
Profit before tax
192
165
Tax
−40
−34
Net profit
153
131
Balance sheet
SEK thousands
Item
2024
2025
Total assets
272
199
Equity
178
159
Long-term debt
—
—
Short-term debt
65
−20
Total debt
65
−20
Financial ratios
5-year trend
EBITDA margin
37.9%
This company
15.8%
Market median
+140% vs market
2024
2025
Equity ratio
79.8%
This company
38.2%
Market median
+109% vs market
2024
2025
Return on equity
82.6%
This company
18.4%
Market median
+349% vs market
2024
2025
Net profit margin
25.5%
This company
8.1%
Market median
+215% vs market
2024
2025
Asset turnover
2.58×
This company
1.12×
Market median
+130% vs market
2024
2025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-08-29 – 2024-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
RS
Roaa Salim
Deputy Board Member
2023
HS
Hussein Salim
Board of Directors
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of RxPharma AB also hold positions in
0
other companies.
Person
Role here
Other companies
Roaa Salim
Deputy Board Member
0 companies
Hussein Salim
Board of Directors
0 companies